Evaluation of peripheral fundus autofluorescence in eyes with wet age-related macular degeneratio
Not Applicable
- Conditions
- wet age-related macular degeneration
- Registration Number
- JPRN-UMIN000018746
- Lead Sponsor
- Department of Ophthalmology and Visual Science Nagoya City University Graduate School of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who diagnosed central serous chorioretinopathy CSC or any other vitreo-retinal diseases.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method prevalence of abnormal peripheral fundus autofluorescence
- Secondary Outcome Measures
Name Time Method the relative risk analyses of abnormal peripheral fundus autofluorescence by disease types and treatments.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie peripheral fundus autofluorescence changes in wet AMD patients?
How does peripheral fundus autofluorescence correlate with standard-of-care treatment outcomes in wet AMD?
Which biomarkers are associated with peripheral fundus autofluorescence patterns in wet AMD progression?
What adverse events are linked to peripheral fundus autofluorescence monitoring in AMD clinical studies?
Are there combination therapies that enhance peripheral fundus autofluorescence as a biomarker in wet AMD?